MedTrace Logo

Melanoma Image Analysis Algorithm (MIAA) Validation Study

NCT02612168 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 514

Last updated 2019-01-25

No results posted yet for this study

Summary

Prospective, single-arm, cross-sectional, study to establish the effectiveness of MIAA to detect melanoma in pigmented lesions, compared to gold standard histological determination.

Conditions

  • Malignant Melanoma

Interventions

DEVICE

Melanoma Image Analysis Algorithm (MIAA)

The images will be analysed by MIAA (Melanoma Image Analysis Algorithm). The MIAA result for PLs that are biopsied will be compared to the diagnosis made from the biopsy. The MIAA result for PLs not biopsied will be compared to clinician diagnosis.

Sponsors & Collaborators

  • Skin Analytics Limited

    lead INDUSTRY

Principal Investigators

  • Ioulios Palamaras, MD PhD · Royal Free London NHS Foundation Trust

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-11
Primary Completion
2018-07-11
Completion
2018-07-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612168 on ClinicalTrials.gov